When planning your 340B strategy health system discussions this fall, selecting the right event can make all the difference. The pharma conference calendar from September to December 2026 is brimming with opportunities to connect with key stakeholders focusing on health system access, formulary influence, and commercial strategy. But which events truly deliver the “signal per hour” when it comes to 340B—where commercial teams can sharpen their competitive intelligence, network meaningfully, and explore innovations like clinical trials modernization?
In this article, we examine three standout gatherings shaping the 340B conversation in Fall 2026: The Health Management Academy (THMA)-led Pharmacy Growth Collaborative 340B sessions, Fierce Pharma Week, and the Drug Pricing Forum Boston. Along the way, we mention insights from companies such as BioInformant, reference modern event tech practices including CookieYes cookie consent and Cloudflare Bot Management (__cf_bm, __cfruid, _cfuvid), and highlight how these conferences align with commercial pharma’s evolving playbook.
Setting the Stage: Fall 2026 Pharma Conference Landscape
The months September through December traditionally host a flurry of pharma meetings, but few zero in on 340B strategy health system concerns with laser focus. The key themes across these events tend to orbit around:
- Health system access and formulary influence: How pharma teams can optimize relationships and advocate for favorable hospital and health system formulary positioning — crucial for 340B-eligible entities. Commercial strategy and competitive intelligence: Benchmarking and tactics to navigate pricing pressures while capturing maximum market share. Clinical trials modernization and decentralized trials: Leveraging new tech and data strategies to streamline trial execution and accelerate product launches.
Your challenge? Selecting conferences where these intersect and deliver on practical, market-ready insights rather than buzzword-laden fluff.
Top Pharma Conferences for 340B Strategy in Fall 2026
Conference Focus Areas Why It Matters for 340B Dates & Location The Health Management Academy (THMA) - Pharmacy Growth Collaborative 340B Health system access, pharmacy growth, 340B program management Deeply tailored sessions specifically designed for 340B program managers, health system executives, and pharma commercial teams. October 18-20, 2026 | Chicago, IL Fierce Pharma Week Commercial strategy, drug pricing, innovation, clinical trials modernization Robust agenda covering competitive intelligence with panels on commercial innovation and pricing pressures affecting 340B dynamics. September 14-17, 2026 | Philadelphia, PA (Hybrid) Drug Pricing Forum Boston Drug pricing policy, reimbursement, advocacy Top-tier forum addressing drug pricing equity and market access challenges—critical topics for 340B strategy adaptation. November 9-11, 2026 | Boston, MAWhat Makes THMA Pharmacy Growth Collaborative 340B the Go-To?
Among the options, THMA’s Pharmacy Growth Collaborative 340B is the closest match if your priority is in-depth engagement on 340B strategy health system topics. THMA’s reputation for convening health system executives and pharmacy leaders creates an ecosystem where pharma commercial teams can access real-world formulary influencers and decision-makers.
Additionally, the meeting emphasizes actionable insights over buzzwords—an antidote to those perennial conference irritants. Recent participants found sessions addressing revised 340B eligibility criteria, program compliance, and growth tactics especially valuable.
Fierce Pharma Week: Commercial Intelligence Meets Innovation
Fierce Pharma Week brings a broader commercial lens and integrates innovation themes like clinical trials modernization and decentralized trials—areas increasingly relevant to pharma teams supporting health systems with 340B programs. Although not solely focused on 340B, Fierce’s rigorous coverage of drug pricing pressure and competitive landscape analysis provides essential context that informs 340B commercial strategy.
Expect thought-provoking panels delving into how decentralized trials could impact formulary submissions and streamline pipeline acceleration—both crucial for pharma's evolving access playbook.
Drug Pricing Forum Boston: Where Policy Meets Practice
The Drug Pricing Forum in Boston merits attention as the policy environment remains a key variable modifying 340B program dynamics. Attending this forum provides upstream intelligence on potential regulatory shifts, pricing frameworks, and advocacy positions shaping the next few years.
For those focused on drug pricing forecast integration into their 340B strategy, this event offers unparalleled value.
Key Technologies Enhancing the Conference Experience
Modern pharma events increasingly embody best-in-class technology. Expect to see sophisticated solutions Extra resources such as:
- CookieYes cookie consent mechanisms ensuring compliance with global privacy regulations—a must-have for digitally savvy commercial teams monitoring in-event digital interactions. Cloudflare Bot Management tools like __cf_bm, __cfruid, and _cfuvid operating behind the scenes to safeguard registration portals and content hubs from non-human traffic, ensuring genuine networking opportunities and data fidelity.
These tools indirectly affect your conference ROI by safeguarding your time and data, ensuring you engage with real peers and competitors rather than bots or spam.
Spotlight on BioInformant: A Data-Driven Contributor to 340B Strategy Conversations
BioInformant stands out as a key player providing data analytics and market intelligence, frequently referenced at these conferences. Their insights on the intersection of health system growth and commercial program execution serve as foundational intelligence for shaping 340B strategies grounded in empirical evidence.
Whether offering whitepapers, panel expertise, or strategy workshops, BioInformant’s footprint in Fall 2026 gatherings amplifies the data-driven tenor of discussions.
Pro Tips: Maximizing Your 340B Strategy Conference Experience
Start with the “Sept-Oct crush” spreadsheet: List sessions, speakers, and networking events at THMA, Fierce Pharma Week, and Drug Pricing Forum to plan high-value touchpoints targeting 340B topics. Evaluate “signal per hour” rigorously: Prioritize panels featuring health system pharm leadership, payer influence, and drug pricing insights over vague marketing claims. Avoid “panels that should have been emails”: Skip sessions heavy on buzzwords ("synergy," "streamline") and light on actionable takeaways. Leverage networking wisely: Focus on solutions-oriented conversations about formulary access, compliance adaptation, and decentralized trial impacts on 340B stakeholders.Conclusion: Which Event Best Supports 340B Strategy Health System Conversations?
For pharma commercial and market access teams laser-focused on 340B, the THMA Pharmacy Growth Collaborative 340B in Chicago this October offers the richest environment tailored precisely to that mission. Yet, don’t discount the broader commercial intelligence and clinical trials innovation Health Management Academy oncology forum 2026 explored at Fierce Pharma Week or the critical pricing and policymaker insights from Drug Pricing Forum Boston. Each fulfills a vital role in a comprehensive Fall 2026 340B strategy playbook.
Integrate learnings from these forums, deploy modern tools like CookieYes cookie consent and Cloudflare Bot Management for a smooth event experience, and harness data from partners like BioInformant to move beyond buzzwords toward business impact.
Your next 340B strategy health system win starts with choosing the right conversations this fall.